The permanent availability of RBC for transfusion depends on refrigerated storage, during which morphologically-altered RBC accumulate. Among those, a subpopulation of small RBC, comprising echinocytes III, sphero-echinocytes, and spherocytes, and defined as "storage-induced micro-erythrocytes" (SME) could be rapidly cleared from the circulation after transfusion. We quantified the proportion of SME in RBC concentrates from healthy human volunteers and assessed their correlation with transfusion recovery. We then investigated the fate of SME upon perfusion through human spleens ex vivo. Finally, we explored where and how SME are cleared in a mouse model of blood storage and transfusion. In healthy human volunteers, high proportions of SME in long-stored RBC concentrates correlated with poor transfusion recoveries. When perfused through human spleens, 15% and 61% of long-stored RBC and SME were cleared in 70 minutes, respectively. High initial proportions of SME also correlated with high retention of RBC by perfused human spleens. In the mouse model, SME accumulated during storage. Transfusion of long-stored RBC displayed reduced post-transfusion recovery, which was mostly due to clearance of SME. Following transfusions of mice, long-stored RBC accumulated predominantly in the spleen, and were ingested mainly by splenic and hepatic macrophages. In macrophage-depleted mice, splenic accumulation and the clearance of SME were delayed and transfusion recovery was improved. In healthy hosts, SME are cleared predominantly by macrophages in the spleen and liver. When this well-demarcated subpopulation of altered RBC is abundant in RBC concentrates, transfusion recovery is diminished. Quantifying SME has the potential to improve blood product quality assessment.
• Check the metadata sheet to make sure that the header information, especially author names and the corresponding affiliations are correctly shown. • Check the questions that may have arisen during copy editing and insert your answers/corrections. • Check that the text is complete and that all figures, tables and their legends are included. Also check the accuracy of special characters, equations, and electronic supplementary material if applicable. If necessary refer to the Edited manuscript. • The publication of inaccurate data such as dosages and units can have serious consequences. Please take particular care that all such details are correct. • Please do not make changes that involve only matters of style. We have generally introduced forms that follow the journal's style. Substantial changes in content, e.g., new results, corrected values, title and authorship are not allowed without the approval of the responsible editor. In such a case, please contact the Editorial Office and return his/her consent together with the proof. • If we do not receive your corrections within 48 hours, we will send you a reminder. Please note Your article will be published Online First approximately one week after receipt of your corrected proofs. This is the official first publication citable with the DOI. Further changes are, therefore, not possible.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.